wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41563422-08B06586-3F76-4255-B600-30470C718CDF
Q41563422-08B06586-3F76-4255-B600-30470C718CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41563422-08B06586-3F76-4255-B600-30470C718CDF
Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.
P2860
Q41563422-08B06586-3F76-4255-B600-30470C718CDF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41563422-08B06586-3F76-4255-B600-30470C718CDF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f54427e83e1474bbfe9b668500240e2f872a5be8
P2860
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.